These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12452476)

  • 1. Clinical use of tumor markers in childhood malignancies.
    Labdenne P; Heikinheimo M
    Ann Med; 2002; 34(5):316-23. PubMed ID: 12452476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
    Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
    J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
    Schneider DT; Calaminus G; Göbel U
    Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
    Lahdenne P; Pitkänen S; Rajantie J; Kuusela P; Siimes MA; Lanning M; Heikinheimo M
    Pediatr Res; 1995 Nov; 38(5):797-801. PubMed ID: 8552451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
    Bekci TT; Senol T; Maden E
    J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of neuron-specific enolase, carbohydrate antigen 19-9 and carbohydrate antigen 125 in carcinoma of the lung.
    Oktay G; Güner G; Karlikaya C; Akkoçlu A
    Biochem Soc Trans; 1995 May; 23(2):211S. PubMed ID: 7672232
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical applications of serum markers for lung cancer.
    Ferrigno D; Buccheri G
    Respir Med; 1995 Oct; 89(9):587-97. PubMed ID: 7494910
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hemodialysis on the concentration of the seven tumor markers carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma-related antigen, neuron-specific enolase, CA 125, CA 19-9 and CA 15-3 in uremic patients.
    Odagiri E; Jibiki K; Takeda M; Sugimura H; Iwachika C; Abe Y; Kihara K; Kihara Y; Itou M; Nomura T
    Am J Nephrol; 1991; 11(5):363-8. PubMed ID: 1725572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dimorphous cancer of the lung].
    Briusov PG; Leonova VV
    Vopr Onkol; 1997; 43(2):205-7. PubMed ID: 9214124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired renal cystic disease and tumor markers in chronic hemodialysis patients.
    Polenakovic M; Sikole A; Dzikova S; Polenakovic B; Gelev S
    Int J Artif Organs; 1997 Feb; 20(2):96-100. PubMed ID: 9093887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological microchip for a simultaneous quantitative immunoassay of tumor markers in human serum.
    Savvateeva EN; Dementieva EI; Tsybulskaya MV; Osipova TV; Ryabykh TP; Turygin AY; Yurasov RA; Zasedatelev AS; Rubina AY
    Bull Exp Biol Med; 2009 Jun; 147(6):737-41. PubMed ID: 19902071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
    Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
    Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
    Yang J; Tang A; Ma J; Sun X; Ming L
    Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular methods for the diagnosis of cancer.
    Cairns P; Sidransky D
    Biochim Biophys Acta; 1999 Mar; 1423(2):C11-8. PubMed ID: 10214347
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoclonal antibodies directed to human lung cancer].
    Kannagi R; Miyake M; Itai S; Naito M; Hashimoto K
    Rinsho Kyobu Geka; 1989 Feb; 9(1):19-28. PubMed ID: 9301894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
    Hui L; Rixv L; Xiuying Z
    Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase.
    Tatekawa Y; Kemmotsu H; Mouri T; Joe K; Ohkawa H
    J Pediatr Surg; 2004 Sep; 39(9):1437-9. PubMed ID: 15359410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.